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Main text
Inherited congenital microcoria (MCOR) [MIM156600], also referred to as congenital miosis, is a rare inborn error of iris development. It is characterized by a small pupil (diameter < 2 mm) that dilates poorly or not at all in response to topically administered mydriatic drugs. Dilation inability results from absent or incompletely developed dilator pupillae muscle. The sphincter pupillae muscle which acts in opposition to the dilator muscle to cause constriction of the pupil is unaltered. In addition to abnormal dilator pupillae muscle, the miotic iris is thin and it displays abnormal stroma and iridocorneal angle. [1] [2] [3] [4] Iris thinning is consistent with transillumination of miotic irises and high sensitivity to light. High myopia and glaucoma are frequently associated with this condition. [5] [6] [7] [8] MCOR is a bilateral disease transmitted as an autosomal dominant trait with complete penetrance. A unique 8 Mb locus on chromosome 13q31-q32 has been mapped in 1998 by linkage analysis 9 in a large multigenerational French pedigree first described in 1964. 10 Gene mapping in some other families confirmed linkage to this locus 11 whereas some others were inconsistent with the 13q31-q32
region, supporting genetic heterogeneity of the disease. 12 Here, we report a study combining Sanger sequencing and array comparative genomic hybridization (CGH) which allowed the identification of the molecular defect underlying the disease at the 13q31-32 locus.
We obtained DNA samples of affected and unaffected members of six MCOR families originating from
France, Japan and Mexico (FR1-2, JP1-2, MX1-2, respectively). Three out of these families were previously reported (FR1, the original family which allowed mapping of the MCOR locus on chromosome 13q31-q32, 9,10 JP1 6 and MX1 4 ). The pedigrees of the families are presented in Figure 1 . Sanger sequencing of the coding region and intron-exon boundaries of genes lying within the 8 Mb MCOR interval on 13q31-q32, and whole exome sequencing combined with linkage analysis failed to detect candidate disease-causing variants segregating with the disease in families FR1 and JP1, respectively (Table S1, Figure S1 ). Considering the strong linkage at the locus in FR1 (Zmax = 9.79,  = 0), 9 we assumed that the mutation in this family was present in an unscreened region or that it might consist in a genomic rearrangement undetectable using PCR-based screening methods. To assess this latter hypothesis, we subjected the DNA of an affected individual (FR1_III7, Figure 1 ) to comparative genomic hybridization (CGH) on high resolution oligonucleotide microarray (Affymetrix Cytogenetics Whole-Genome 2.7M Array). Calculation of test over reference Log2 intensity Ratios identified a 54.8 Kbp deletion in the 13q32.1 region (Figure 2 , Figure S2 ). We amplified the junction fragment by subjecting the genomic DNA of the index case to PCR using primers designed just outside of the predicted deletion boundaries (Table S2 , Figure S3 ). Direct sequencing of the 1. Figure 2 ).
Interestingly, multiplex PCR of short fluorescent fragments (QMPSF) 13 using primer pairs specific to GPR180, TGDS and a control gene (CFTR, NM_000492.3, Table S3 ) suggested hemizygosity at 13q32.1 in the other French family as well as the two Japanese and two Mexican MCOR families ( Figure S4 ). In all five families, array CGH confirmed the presence of 13q32.1 deletions, which estimated sizes ranged from 39 Kbp to 88.9 Kbp ( Figure S2 ). Direct sequencing of intervening segments amplified using primers designed just outside of the predicted breakpoints (Table S2) showed Figure 2 ).
In family MX2, we failed to amplify the intervening segment using primers designed with array CGH data. Considering that MX1 and MX2 families had the same ethnic background and shared the same predicted distal deletion breakpoint (Table 1 and Figure S2 ) we assumed that both families could have inherited the same deletion by descent and that, in corollary, lack of amplification of the junction fragment in family MX2 could result from incorrectly predicted proximal deletion breakpoint. Using the primers designed to amplify family MX1 junction fragment, we were able to amplify family MX2 intervening segment ( Figure S3 ). Direct sequencing demonstrated the two families shared the exact same deletion (Table 1 and Figure 2 ). Analysis of microsatellite markers of chromosome 13q31-q32
showed that the deletion was carried by a common 6.4 Mb haplotype suggesting that it might have been transmitted within both families by a common ancestor ( Figure S5 ).
Deletion fragment-specific PCR assays based on the amplification of intervening segments in all available DNA samples (see Figure 1 ) allowed us to confirm the co-segregation of the deletions with the disease in 4/6 families ( Figure S3 ). Segregation analysis could not be performed in Families FR2
and JP2 because of a lack of DNA samples. Positive PCR amplification of intragenic GPR180
fragments confirmed heterozygosity of all deletions (not shown). Figure S6 ).
Recently, several microhomology-mediated repair mechanisms have been described in the etiology of non-recurrent CNVs in human disease. [14] [15] [16] These mechanisms, which are guided by the surrounding genomic architecture, include microhomology-mediated end-joining (MMEJ), 17 fork stalling and template switching (FoSTeS), 18 microhomology-mediated break-induced replication (MMBIR), 19 serial replication slippage (SRS), 20 and break-induced SRS (BISRS). 21 Extensive bioinformatic analysis of MCOR deletion breakpoints and surrounding genomic architecture allowed the identification of perfectly matching 1 or 2 base pairs shared between the proximal and distal sequence at the junctions, sequence motifs and/or repetitive elements which are likely to stimulate the formation of the 13q32.1 deletions by increasing susceptibility of DNA breakage or promote replication fork stalling (Table S4 , Figures S6-7 ). These findings are consistent with the view that microhomology-mediated mechanisms underlie non-recurrent MCOR deletions in families FR1, JP1, JP2, MX1 and MX2.
The minimal common deletion disrupted GPR180 and TGDS (Table 1 and Figure 2 ), raising the possibility that haploinsufficiency of one or the two genes, or alternatively the loss of regulatory elements, might give rise to the phenotype.
GPR180 encodes a 201 amino-acid G protein-coupled receptor 22 of the Rhodopsin-like receptors family which includes hormones, neurotransmitters, and light receptors, all of which transduce extracellular signals upon interaction with guanine nucleotide-binding proteins and activating ligands.
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Very little is known about the function of GPR180. However, it has been reported to be produced predominantly in vascular smooth muscle cells where its expression is upregulated in response to experimental injury. 24 The significant suppression of DNA synthesis and inability to produce neointima in response to vascular injury in the Gpr180-/-mouse suggest that upregulation of Gpr180 signaling contributes to vascular smooth muscle growth. 22 In addition, gene expression profiling in normal human tissues have shown that it is highly expressed in myoepithelia (salivary gland, endomyometrium, prostate, lung and liver). 25 In the eye, GPR180 is less abundant than in myoepithelia. However, it is listed in the top 20 genes having a significantly higher expression in the iris compared to the other ocular structures. 26 Hence, considering that the dilator pupillae arises during embryonic life by the differentiation of iris epithelial cells into myoepithelial cells, 27, 28 GPR180 was regarded as a strong candidate MCOR gene.
The Gpr180-/-mouse had resistance to experimental thickening of the intima but normal appearance, growth rate, reproduction, and histology of major organs. 22 We examined Gpr180-/-and Gpr180+/-mice for anterior segment development and iris function. We found that both heterozygote and
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homozygote Gpr180-null eyes were undistinguishable from adult age-matched controls ( Figures S8-S10 ). In particular, we found no iris transillumination and normal drug-mediated mydriasis both in heterozygote and homozygote Gpr180-null mice.However, inspection of our in house exome database The reason why heterozygosity for the p.Gln115* substitution was not sufficient to cause the full range of MCOR symptoms could reside in the production of a truncated protein retaining some of its function.
Alternatively, premature termination codon (PTC) self-correcting mechanisms could be involved, in particular translational read-through which has recently been reported to be more abundant than expected in higher species, including human. 29 Nonsense-associated altered splicing (NAS), which consists in selective exclusion of an in-frame exon with a premature termination codon, is another possible correcting mechanism. [30] [31] [32] [33] Recently, a nonsense mutation in CEP290 which mutations cause blindness has been shown to induce exon skipping and to lead to a relatively mild retinal phenotype. 34 Because the skipping of GPR180 exon 2 would not disrupt the open reading frame, NAS could explain why the p.Gln115* substitution is not as detrimental as gene ablation.
The p.Gln115* substitution was not reported in the Exome Aggregator database (ExAC), Exome
Variant Server (EVS), 1000Genome and dbSNP datasets. However, we identified in the ExAC database twelve other rare variants which may cause protein truncation (6 nonsense and 6 frameshift mutations, 0.00004 <minor allele frequency <0.000008; Table S5 ). Provided that these variants are confirmed, studying their molecular consequence at the mRNA and/or the protein levels and, knowing the ophthalmologic status of carrier individuals will certainly help in understanding the role of GPR180 in MCOR and goniodysgenesis. Meanwhile, to address this important question, we screened the GPR180 exome for mutations in a series of individuals having an eye disease with goniodysgenesis, including ten individuals with Axenfeld-Rieger anomaly or Peters anomaly [MIM604229] and no PAX6, PITX2, FOXC1, CYP1B1, MAF or MYOC mutation (n = 5 and n = 5, respectively), and eleven index cases of primary congenital glaucoma (n = 9) or juvenile glaucoma (n = 2) with no CYP1B1 mutations.
Primer sequences are given in Table S6 . No GPR180 candidate disease variants were identified in GPR180 exon and intron-exon boundaries in any of the individuals.
Despite strong arguments in favor of the involvement of GPR180 in MCOR, in the absence of 13q32.1 deletions which do not disrupt TGDS, or of a GPR180 mutation that causes the full MCOR phenotype, we cannot formally exclude that haploinsufficiency of GPR180 is necessary, but not sufficient, for MCOR to manifest. enzymes display a wide substrate spectrum, ranging from steroids, alcohols, sugars, and aromatic compounds to xenobiotics. 35 TGDS catalyses the dehydration of dTDP-alpha-D-glucose into dTDP-4-dehydro-6-deoxy-alpha-D-glucose. It contributes to deoxy-sugar metabolism, 35, 36 but its exact function is unknown. In bacteria, TGDS is essential to the biogenesis of cell envelope components and antibiotics, 37 while in C. elegans, it is required for normal growth rates, larval development and survival, reproduction and coordinated locomotion. 38 In human eyes, TGDS expression is lower than that of GPR180, and unlike this latter, it has no preferential expression in the iris 26 and a unique form of bilateral hyperphalangy causing clinodactyly of the index finger (HP:0009467). 39 Neither the affected individuals, nor their heterozygote parents are reported to have eye disease. 39 Therefore, it is unlikely that TGDS dysfunction in human is responsible for MCOR.
Finally, it cannot be excluded that full range of MCOR symptoms are due to both the loss of GPR180 function and to that of elements that regulate the expression of neighboring genes by position effect. 8 in the biosynthetic pathway of eumelanin in pigment cells. In the mouse, Dct mutations cause the Slaty phenotype in which the iris is normal in the first months of life. Later-on, age-related dispersed pigment across the surface of the iris combined with mild transillumination is noted 40 . To our knowledge, no DCT mutation is reported in human disease so far but 10 loss-of-function alleles are described in EVS.
One of these variants, p.Tyr75Serfs*50 is homozygous in 12/6249 individuals, making unlikely a contribution of DCT loss-of-function in MCOR. However, considering that pigmentation has a role on the development of the neuroretina, 41, 42 it cannot be excluded that 13q32.1 deletions cause DTC overexpression and dysregulate iris development mechanisms.
SOX21 is located 75 kbp upstream of the distal boundary of the minimal MCOR interval (Figure 2 ).
Sox21 has been reported to be a general mediator of the effects of Sox2 43 which interaction with Pax6 is crucial to coordinate eye development 44 . It is known to be expressed in the developing lens in chicken 45 and zebrafish. 46 Additionally, sox21b knock-down in the zebrafish causes lens malformation. 47 In the mouse, complete inactivation of Sox21 has been reported to cause cyclic alopecia, 48 but the ocular phenotype of the animal is unknown. Altered regulation of SOX21 expression in MCOR individuals cannot be excluded.
In summary, here we report heterozygote 13q32.1 deletions in 6/6 MCOR families of variable ethnic origin, which invariably encompass GPR180 and TGDS. We suggest that GPR180 ablation, alone or in combination with the loss of elements that regulate the expression of neighboring genes by position effect, is the cause of the disease. Further studies will hopefully allow the identification of the molecular mechanisms underlying this rare disease. It should provide further insights into the development of the anterior chamber of the eye, which anomalies are an important cause of visual loss due to glaucoma.
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